Related Experiment Video
Updated: Jun 7, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Platelet hypoaggregation in iron deficiency anaemia: reversible with therapy
H P Pati1, V L Bhargava, A K Saraya
1Department of Haematology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Abstract:
The effect of anaemia on in vitro platelet aggregation (PA) parameters (rate, degree and latent period prior to aggregation) were measured in platelet-rich plasma from 30 adult patients (15 males, 15 females) with iron deficiency anaemia and in 20 age-matched control subjects (10 males, 10 females). PA, in response to adenosine diphosphate (ADP), collagen and arachidonic acid, plasma fibrinogen and serum iron parameters were measured prior to putting the patients on iron therapy. And after correction of anaemia the PA and fibrinogen measurements were repeated. The rate and degree of PA with all agonists (except the lowest concentration of ADP) were significantly lower in anaemic patients than in control and in post-therapy subjects (P<0.05-0.001). When the iron parameters were kept constant, haemoglobin showed significant correlation with rate and degree of PA with ADP (P<0.05 each) before therapy and with arachidonic acid (P<0.05 each) after therapy. However, when haemoglobin was kept constant there was no correlation between PA and iron parameters. These results suggest that red cell mass is an important factor in PA and anaemia could lessen the contributory role of platelets in thrombosis.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

